BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 28520851)

  • 1. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
    Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
    Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
    Mondal D; Bern C; Ghosh D; Rashid M; Molina R; Chowdhury R; Nath R; Ghosh P; Chapman LAC; Alim A; Bilbe G; Alvar J
    Clin Infect Dis; 2019 Jul; 69(2):251-258. PubMed ID: 30357373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.
    Khan MAA; Faisal K; Chowdhury R; Nath R; Ghosh P; Ghosh D; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2021 Sep; 14(1):465. PubMed ID: 34503557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission.
    Le Rutte EA; Zijlstra EE; de Vlas SJ
    Trends Parasitol; 2019 Aug; 35(8):590-592. PubMed ID: 31266711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short report: Leishmania DNA in Phlebotomus and Sergentomyia species during a kala-azar epidemic.
    Mukherjee S; Hassan MQ; Ghosh A; Ghosh KN; Bhattacharya A; Adhya S
    Am J Trop Med Hyg; 1997 Oct; 57(4):423-5. PubMed ID: 9347957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of Parasite Kinetics in Indian Post-Kala-azar Dermal Leishmaniasis.
    Moulik S; Chaudhuri SJ; Sardar B; Ghosh M; Saha B; Das NK; Chatterjee M
    Clin Infect Dis; 2018 Jan; 66(3):404-410. PubMed ID: 29020350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL).
    Kumar A; Singh VK; Madhukar P; Tiwari R; Roy R; Rajneesh ; Mehrotra S; Sundar S; Kumar R
    Mol Biol Rep; 2024 Jun; 51(1):716. PubMed ID: 38824237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
    Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P
    Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Use of Forensic DNA Methods Applied to Sand Fly Blood Meal Analysis to Identify the Infection Reservoirs of Anthroponotic Visceral Leishmaniasis.
    Inbar E; Lawyer P; Sacks D; Podini D
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004706. PubMed ID: 27192489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
    Singh A; Ramesh V; Ramam M
    Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Upadhyay S; Singh AK; Singh OP; Sundar S; Singh R; Salotra P
    J Clin Microbiol; 2021 Aug; 59(9):e0013221. PubMed ID: 34160275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.